Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum urate level and cancer.

E Lickl1, G Alth, R Ebermann

  • 1Ludwig Boltzmann Institut fuer klinische Onkologie, Vienna, Austria.

Medical Hypotheses
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypericin--the facts about a controversial agent.

Current pharmaceutical design·2005
Same author

Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling.

Nutrition and cancer·1999
Same author

5-aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix--a new experimental approach.

Cancer detection and prevention·1999
Same author

Antagonistic effects of combination photosensitization by hypericin, meso-tetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus.

Drugs under experimental and clinical research·1999
Same author

Ambulant photodynamic therapy of superficial malignomas with 5-ALA in combination with folic acid and use of noncoherent light.

Drugs under experimental and clinical research·1999
Same author

Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.

Biologicals : journal of the International Association of Biological Standardization·1998

Cancer patients exhibit significantly lower serum uric acid levels compared to healthy individuals. This finding supports the role of reactive oxygen species in cancer development.

Area of Science:

  • Biochemistry
  • Oncology
  • Free Radical Chemistry

Background:

  • Serum uric acid levels are influenced by various factors, including physiological and pathological conditions.
  • Reactive oxygen species (ROS) are implicated in cellular damage and disease processes, including cancer.
  • Understanding the relationship between uric acid and cancer may offer insights into disease mechanisms.

Purpose of the Study:

  • To compare serum uric acid levels between cancer patients and healthy controls.
  • To investigate the potential association between serum uric acid levels and carcinogenesis.
  • To evaluate the role of reactive oxygen species in cancer development.

Main Methods:

  • Serum uric acid levels were measured in a cohort of 501 cancer patients and 15,150 healthy controls.

Related Experiment Videos

  • Histograms were used to visualize and compare the distribution of uric acid levels.
  • Statistical analysis (P-values) was performed to determine the significance of observed differences.

    • Main Results:

    • Cancer patients demonstrated significantly lower serum uric acid levels compared to healthy controls (P < 0.0001 for males, P < 0.001 for females).
    • The observed difference was statistically significant across both genders.
    • Uric acid levels showed a clear distinction between the cancer patient group and the control group.

    Conclusions:

    • Lower serum uric acid levels in cancer patients suggest a potential link between uric acid metabolism and cancer.
    • These findings support the hypothesis that reactive oxygen species, such as singlet oxygen and oxygen radicals, are involved in the process of carcinogenesis.
    • Further research is warranted to explore the therapeutic and diagnostic implications of these findings.